Carcinoembryonic Antigen (CEA) Testing Market, By Application (Ovarian Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, and Thyroid Cancer), By Gender (Male and Female), By End User (Diagnostic Centre, Cancer Centre, Hospitals, and Research Laboratories) and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2020-2026
REPORT HIGHLIGHT
Carcinoembryonic antigen (CEA) testing market was valued at USD 2.36 billion by 2019, growing with 6.4% CAGR during the forecast period, 2020-2026.
Carcinoembryonic antigen or CEA is a group of glycoprotein present in the body fluids of the embryo, fetus, and gastrointestinal tract. CEA is normally found in the embryonic entodermal epithelium. CEA is also present in the mucosal cells of the gastrointestinal cells, colorectum, and small amounts in the blood. The gastrointestinal tissue produces carcinoembryonic antigen during the development of fetal. The CEA test is especially used for cancers of the large intestine and the rectum. It is one of the most commonly used tumor markers worldwide.
Market Dynamics
The increasing prevalence of cancer, rising per capita healthcare expenditure, and growing demand for minimally invasive diagnostic procedures are the major factors boosting the growth of the global carcinoembryonic antigen market. In addition, the rapidly rising geriatric population who are prone to chronic medical conditions such as cancer is likely to fuel market growth. According to the World Health Organization (WHO), around 43.8 million of the total world population was suffering from cancer in 2018. Furthermore, the constant development and introduction of novel immunological techniques, such as radioimmunoassay are predicted to create lucrative growth opportunities in the overall market during the forecast period. However, the side-effects and risk of infections associated with CEA testing are expected to hamper the market growth in the coming future.
Testing Types Takeaway
“Enzyme-Linked Immunoassay accounted for the highest revenue share”
CEA level in the human blood can be measure through various testing such as Electro-chemiluminescence immunoassay (ECLIA), enzyme-linked immunoassay (EIA), radio-immunoassay (RIA), and others. Though all the above-mentioned testing methods are used to quantify the CEA level, their sensitivity may vary. Among these, the EIA method is considered to be the most preferable clinical practice. This is because of the use of radioisotopes and thus, it offers effective and accurate diagnostic power.
Application Takeaway
“Colorectal segment to hold the largest market share during the forecast period”
Based on the application, the global carcinoembryonic antigen market is categorized into ovarian cancer, colorectal cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, and thyroid cancer. Among these, the colorectal cancer segment subjugated the global market in 2019 and is estimated to hold the largest market share in terms of revenue during the forecast period. This is majorly owing to a surge in demand for minimally invasive diagnostic procedures, a growing prevalence of unhealthy lifestyles, and a rising geriatric population. In addition, unhealthy dietary habits and increasing consumption of alcohol are other factors contributing to the segmental market growth. On the other hand, the breast cancer segment is estimated to grow at the fastest rate during the period of forecast owing to the growing demand for cosmetic surgeries & hormone replacement therapy (HRT) and a rise in the number of female populations all over the world.
Gender Takeaway
“Male segment to account for the majority of market share by 2026”
On the basis of gender, the overall CEA market is bifurcated into male and female. Of these, the male segment accounted for the largest market share in 2019 owing to more prevalence of cancer in men as compared to women. According to the NIH’s National Institute of Cancer, cancer prevalence is higher among men with 196.8 per 100,000 men. However, in women, it is 139.6 per 100,000 women. In addition, certain risk factors, such as drinking and smoking affect more to men than women. On the other hand, the female segment is anticipated to grow at a significant rate by the end of 2026 owing to the growing occurrences of breast cancer.
End-User Takeaway
“Hospitals segment to be most lucrative in the forecast period”
Based on end-user, the worldwide CEA market is categorized into hospitals, diagnostic, and cancer centers. and research laboratories. Among these, the hospital segment accounted for the majority of share in the market in 2019 and is expected to lead the worldwide market by 2026. This is primarily owing to the growing incidence of cancer all over the world. Besides, CEA tests in hospitals have various benefits such as staying connected to the healthcare system through IoT (Internet of Things), and improved diagnosis accuracy along with sophisticated healthcare infrastructure.
Regional Takeaway
“North America region to dominate the global industry until 2026”
Depending on the region, the global industry is divided into North America, Europe, Middle East & Africa, Asia Pacific, and Latin America. The North American market for CEA played a dominant role in 2019 and is expected to continue its dominance throughout the forecast. This is mainly attributed to the presence of well-established healthcare infrastructure, high occurrence rates of cancer, and higher expenditure levels.
Along with North America, the Asia Pacific region is expected to grow at a rapid pace in the global market during the period of forecast owing to constantly improving infrastructure for healthcare. Moreover, the economic development, presence of untapped opportunities, and increasing patient awareness levels are other factors expected to contribute to the regional market growth in the coming future. Also, this region has the highest mortality rate due to the high prevalence of cancer.
COVID-19 Impact
Adapting to the recent novel coronavirus crisis, the COVID-19 has progressively impacted the global carcinoembryonic antigen market. The thorough analysis of the COVID-19 pandemic on the overall market is included in the research report. The influence of the novel COVID-19 pandemic on the growth of the CEA market is analyzed and depicted in the research report.
Key Vendor Takeaway
The leading players operating in the global CEA market include Correlogic Systems, Inc., GenWay Biotech Inc., Omega Diagnostics Group, Creative Diagnostics, Boster Biological Technology, Quest Diagnostics, Abbott Laboratories, Lee Biosolutions, RayBiotech, Amgen, and Roche Diagnostics. Among these, Abbott was emerged as the leading players, accounted for the significant market share in 2019. The company’s global presence coupled with a wide product portfolio has helped Abbott to capture a large customer base.
In addition, key players are actively involved in investing in R&D activities to develop new products. In October 2019, a biotechnology company, SurgiMab, announced that the first patient in the U.S. has been recruited for its on-going pivotal Phase 3 clinical trial for colorectal cancer surgery with the carcinoembryonic antigen test. This trail evaluates its investigational imaging agent namely, ‘SGM-101’ in cancer patients undergoing surgery.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
CARCINOEMBRYONIC ANTIGEN (CEA) MARKET KEY PLAYERS
- Correlogic Systems, Inc.
- GenWay Biotech Inc.
- Omega Diagnostics Group
- Creative Diagnostics
- Boster Biological Technology
- Quest Diagnostics
- Abbott Laboratories
- Lee Biosolutions
- RayBiotech
- Amgen
- Roche Diagnostics
CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY TESTING TYPE
- Enzyme-Linked Immunoassay (EIA)
- Radio-Immunoassay (RIA)
- Electro-Chemiluminescence Immunoassay (ECLIA)
- Others
CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY APPLICATION
- Ovarian Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Thyroid Cancer
- Others
CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY GENDER
- Male
- Female
CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY END USER
- Diagnostic Centre
- Cancer Centre
- Hospitals
- Research Laboratories
- Others
CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Testing Type
2.1.2. Market Snippet by Application
2.1.3. Market Snippet by Gender
2.1.4. Market Snippet by End User
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET – BY TESTING TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Testing Type, 2019 & 2026 (%)
6.2. Enzyme Linked Immunoassay (EIA)
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Radio-Immunoassay (RIA)
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. Electro-Chemiluminescence Immunoassay (ECLIA)
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.5. Others
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET – BY APPLICATION
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
7.2. Ovarian Cancer
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Colorectal Cancer
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Pancreatic Cancer
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5. Breast Cancer
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.6. Lung Cancer
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.7. Prostate Cancer
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.8. Thyroid Cancer
7.8.1. Overview
7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.9. Others
7.9.1. Overview
7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET – BY GENDER
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
8.2. Male
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Female
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET – BY END USER
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2019 & 2026 (%)
9.2. Hospitals
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3. Research Laboratories
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4. Diagnostic Centre
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.5. Cancer Centre
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.6. Others
9.6.1. Overview
9.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10. CARCINOEMBRYONIC ANTIGEN (CEA) TESTING MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.2.4. North America Market Size and Forecast, By Testing Type, 2015 – 2026 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.2.6. North America Market Size and Forecast, By Gender, 2015 – 2026 (US$ Million)
10.2.7. North America Market Size and Forecast, By End User, 2015 – 2026 (US$ Million)
10.2.8. U.S.
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.2.9. Canada
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Testing Type, 2015 – 2026 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Gender, 2015 – 2026 (US$ Million)
10.3.7. Europe Market Size and Forecast, By End User, 2015 – 2026 (US$ Million)
10.3.8. Germany
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.10. United Kingdom
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.11. France
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.12. Rest of Europe
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Testing Type, 2015 – 2026 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Gender, 2015 – 2026 (US$ Million)
10.4.7. Asia Pacific Market Size and Forecast, By End User, 2015 – 2026 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.9. China
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.11. South Korea
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.12. Rest of APAC
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Testing Type, 2015 – 2026 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Gender, 2015 – 2026 (US$ Million)
10.5.7. Latin America Market Size and Forecast, By End User, 2015 – 2026 (US$ Million)
10.5.8. Brazil
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.9. Mexico
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.10. Argentina
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Testing Type, 2015 – 2026 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Gender, 2015 – 2026 (US$ Million)
10.6.7. Middle East and Africa Market Size and Forecast, By End User, 2015 – 2026 (US$ Million)
10.6.8. Saudi Arabia
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6.9. United Arab Emirates
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Omega Diagnostics Group
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Application Benchmarking
11.1.4. Strategic Initiatives
11.2. GenWay Biotech Inc.
11.3. Quest Diagnostics
11.4. Abbott Laboratories
11.5. Creative Diagnostics
11.6. Boster Biological Technology
11.7. Correlogic Systems, Inc.
11.8. Lee Biosolutions
11.9. RayBiotech
11.10. Amgen
11.11. Roche Diagnostics
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Carcinoembryonic Antigen (CEA) Testing market: Application Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Application 2015-2026 (USD Million)
TABLE Carcinoembryonic Antigen (CEA) Testing market: Gender Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Gender
TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Gender 2015-2026 (USD Million)
TABLE Carcinoembryonic Antigen (CEA) Testing market: Testing Type Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Testing Type
TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Testing Type 2015-2026 (USD Million)
TABLE Carcinoembryonic Antigen (CEA) Testing market: End User Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by End User
TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by End User2015-2026 (USD Million)
TABLE Carcinoembryonic Antigen (CEA) Testing market: Regional Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Carcinoembryonic Antigen (CEA) Testing market, by Region 2015-2026 (USD Million)
TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
TABLE North America Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
TABLE Europe Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
TABLEAsia Pacific Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
TABLE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
TABLE Latin America Carcinoembryonic Antigen (CEA) Testing market, by End User, 2015-2026 (USD Million)
TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Country, 2015-2026 (USD Million)
TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Testing Type, 2015-2026 (USD Million)
TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Application, 2015-2026 (USD Million)
TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Gender, 2015-2026 (USD Million)
TABLE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market, by Distribtion Channel, 2015-2026 (USD Million)
List of Figures
FIGURE Carcinoembryonic Antigen (CEA) Testing market segmentation
FIGURE Market Research Methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Testing Type segment market share analysis, 2019 & 2026
FIGURE Testing Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Enzyme-Linked Immunoassay (EIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Radio-Immunoassay (RIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Electro-Chemiluminescence Immunoassay (ECLIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Application segment market share analysis, 2019 & 2026
FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Ovarian Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Colorectal Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Pancreatic Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Breast Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Lung Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Prostate Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Thyroid Cancer market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Gender segment market share analysis, 2019 & 2026
FIGURE Gender segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Male market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Female market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE End User segment market share analysis, 2019 & 2026
FIGURE End User segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Hospitals market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Research Laboratories market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Diagnostic Centre market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cancer Centre market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
FIGURE Europe Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
FIGURE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
FIGURE Latin America Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
FIGURE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market share and leading players, 2018
FIGURE North America Carcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
FIGURE U.S. Carcinoembryonic Antigen (CEA) Testing Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Carcinoembryonic Antigen (CEA) Testing Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Carcinoembryonic Antigen (CEA) Testing Market share analysis by country, 2018
FIGURE Germany Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE FranceCarcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Carcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
FIGURE India Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APACCarcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin AmericaCarcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
FIGURE BrazilCarcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Carcinoembryonic Antigen (CEA) Testing market share analysis by country, 2018
FIGURE Saudi Arabia Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Carcinoembryonic Antigen (CEA) Testing market size, forecast and trend analysis, 2015 to 2026 (USD Million)
